2020
DOI: 10.1016/j.jval.2020.08.902
|View full text |Cite
|
Sign up to set email alerts
|

PIN61 Cost-Effectiveness Study of the Use of Dolutegravir Compared with Efavirenz in Combination with Tenofovir and Emtricitabine, As the First LINE for the Care of Patients NEWLY Diagnosed with HIV or WHO Have NOT Started ART in Colombia.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles